Blueprint Medicines (NASDAQ:BPMC) reported earnings of ($1.83) per share missing Walls Streets expectations.

Blueprint Medicines (NASDAQ:BPMC) reported 12/31/2018 earnings this Morning, coming in at ($1.83) per share, missing Wall Street’s estimates of ($1.68) per Share. Revenue for the quarter came in at $1.03 million missing the streets estimates of $1.77 million

      Story continues below

      Recent Trading for Blueprint Medicines (NASDAQ:BPMC)
      Shares of Blueprint Medicines closed the previous trading session at with 75.5 shares trading hands.

      An ad to help with our costs